Manulife (Manufacturers Life Insurance)
NBSE

Manulife (Manufacturers Life Insurance)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-562
Closed -$85K – 3035
2020
Q3 		$85K Hold
562
– – ﹤0.01% 2832
2020
Q2 		$100K Buy
+562
New +$94.1K ﹤0.01% 2756
2015
Q2 		– Sell
-39
Closed -$40 – 4131
2015
Q1 		$40 Buy
39
+1
+3% +$3.3K ﹤0.01% 3379
2014
Q4 		$126 Buy
38
+3
+9% +$9.2K ﹤0.01% 2958
2014
Q3 		$100 Buy
+35
New +$116K ﹤0.01% 3098

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NBSE Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q4 2020, closing a stake of 562 shares — an estimated $85K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NBSE in Q3 2014 and held it in 5 quarters. The position peaked at $100K in Q2 2020. 53 funds tracked by Wall St. Rank hold NBSE as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 562 NeuBase Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $85K.
  • Manulife (Manufacturers Life Insurance) first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s NeuBase Therapeutics, Inc. Common Stock position peaked at $100K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.